A settlement to resolve all outstanding state and federal Digitek lawsuits has been reached.

According to federal court records, attorneys for plaintiffs and defendants informed the U.S. District Judge Joseph Goodwin on September 1 that they have reached an agreement to settle multiple Digitek lawsuits.

These lawsuits were brought on behalf of hundreds of people who allege they suffered an injury as a result of an overdose on Digitek. The cases date back to the 2008 Digitek recall that was issued after the drug maker allegedly distributed pills that contained too large of an amount of the drug to consumers nationwide.

Hundreds of Digitek lawsuits have been filed in state courts and federal district courts throughout the country. The federal Digitek litigation is consolidated and centralized before Judge Goodwin in the U.S. District Court for the Southern District of West Virginia as part of a multidistrict litigation.

Judge Goodwin assigned a “Special Master” who will be crucial to determining the amount of compensation each individual plaintiff will receive from the settlement. The Special Master will resolve claims for both federal and state cases.

Digitek is a generic version of the drug digoxin, which is used to treat congestive heart failure, abnormal heart rhythms, atrial flutter and atrial fibrillation. The medication is extremely dose-specific with a narrow therapeutic index. If too little of drug is prescribed it can be ineffective, and if too much is prescribed it can lead to a Digitek overdose, where the drug builds up in the system. This can result in a serious and potentially life-threatening condition known as digitalis toxicity.

Actavis Totowa issued a Digitek recall for all lots of the heart drug after it was discovered that some tablets may have been commercially released that were twice as thick as they were supposed to be. The error potentially exposed thousands of users to a risk of digoxin overdose or poisoning.

According to a December 2008 report released by the non-profit Center for Public Justice, the FDA received reports of at least 667 Digitek overdose deaths tied to the recalled pills between April 2008 and June 2008.